Antibiotics | Free Full-Text | Pharmaceutical Approaches on Antimicrobial Resistance: Prospects and Challenges
New Antibiotic for Urinary-Tract Infections Found Effective in Trials - WSJ
New Urinary Tract Infections Clinical Trial: Gepotidacin for Urinary Tract Infections - YouTube
Gepotidacin for Urinary Tract Infection Clinical Trial 2023 | Power
Intracellular concentration-response curves of gepotidacin (GEP)... | Download Scientific Diagram
Gepotidacin (GSK2140944) | Cas# 1075236-89-3 - GlpBio
Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | Antimicrobial Agents and Chemotherapy
Antibiotics | Free Full-Text | Antibacterial Activity of the Novel Drug Gepotidacin against Stenotrophomonas maltophilia—An In Vitro and In Vivo Study
Dose Selection for a Phase 3 Study Evaluating Gepotidacin (GSK2140944) in the Treatment of Gonorrhoea | GSK
TITLE PAGE
Dose Selection for Phase 3 Studies Evaluating Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | GSK
GSK to submit drug application for new antibiotic to US FDA - PMLiVE
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase | ACS Infectious Diseases
gepotidacin - Drug Hunter
How to Treat Urinary Tract Infections (UTI): GSK's Gepotidacin May Work - Bloomberg
Safety Trial of New Antibiotic - YouTube
Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants | SpringerLink
Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants wi
Gepotidacin (GSK2140944) Demonstrates Similar Safety and Pharmacokinetics in Adults and Adolescents (12 to ˂18 years) | GSK
Pharmacokinetics of Oral Formulations of Gepotidacin (GSK2140944), a Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor, in Healthy Adult and Adolescent Participants | Antimicrobial Agents and Chemotherapy
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose- Ranging, Single-Oral Dose Eva
GSK stops two Phase 3 studies for gepotidacin stopped early
First Novel Antibiotic Since 20 Years, Gepotidacin Debuts To Treat Drug Resistance Urinary Tract Infections (UTIs) Amidst Growing Incidences! - Thailand Medical News
